# A Thorough EKG Safety Study of TA-1790 (Avanafil)

> **NCT00769041** · PHASE1 · COMPLETED · sponsor: **VIVUS LLC** · enrollment: 57 (actual)

## Conditions studied

- Erectile Dysfunction

## Interventions

- **DRUG:** moxifloxacin
- **DRUG:** avanafil
- **DRUG:** avanafil
- **DRUG:** sugar pill

## Key facts

- **NCT ID:** NCT00769041
- **Lead sponsor:** VIVUS LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2009-01
- **Final completion:** 2009-01
- **Target enrollment:** 57 (ACTUAL)
- **Last updated:** 2011-01-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00769041

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00769041, "A Thorough EKG Safety Study of TA-1790 (Avanafil)". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00769041. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*